guanethidine has been researched along with Wallerian Degeneration in 1 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
Wallerian Degeneration: Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heath, JW | 1 |
| Kidd, GJ | 1 |
| Trapp, BD | 1 |
| Dunkley, PR | 1 |
1 other study available for guanethidine and Wallerian Degeneration
| Article | Year |
|---|---|
Myelin maintenance by Schwann cells in the absence of axons.
Topics: Animals; Axons; Cell Membrane; Ganglia, Sympathetic; Guanethidine; Mice; Myelin Sheath; Nerve Regene | 1991 |